{"database": "lobbying", "table": "lobbying_activities", "rows": [[1694383, "3168b55d-cb16-405c-ac85-ef3daf2eff99", "Q2", "O'NEILL AND ASSOCIATES", 73134, "THE JETT FOUNDATION", 2015, "second_quarter", "MED", "FDA issues. Seeking accelerated approval for breakthrough medical treatments to treat Duchenne Muscular Dystrophy", "HOUSE OF REPRESENTATIVES,SENATE", 20000, null, 0, 0, "2015-07-14T11:48:53.717000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1694383"], "units": {}, "query_ms": 0.34996692556887865, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}